Clinical Trials Logo

Clinical Trial Summary

This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.


Clinical Trial Description

Interviews are conducted over the telephone and require approximately 90 minutes to complete. Men interviewed are compensated for their participation in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00717613
Study type Observational
Source Baylor College of Medicine
Contact
Status Completed
Phase N/A
Start date July 2007
Completion date October 2011

See also
  Status Clinical Trial Phase
Completed NCT03996005 - MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer N/A
Withdrawn NCT02159690 - A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy Phase 2
Completed NCT00196781 - Treatment Decision Making in Early-Stage Prostate Cancer Phase 3
Recruiting NCT03821246 - Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy Phase 2
Active, not recruiting NCT03814252 - Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer N/A
Completed NCT01931046 - Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer Phase 1/Phase 2
Completed NCT01714219 - Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy N/A
Active, not recruiting NCT03315754 - Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. Phase 2
Recruiting NCT05010343 - Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer Phase 2
Recruiting NCT06325995 - Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer N/A
Recruiting NCT06051942 - PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs N/A
Completed NCT02297386 - [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer Phase 1
Not yet recruiting NCT06117059 - The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance N/A
Withdrawn NCT04225299 - Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer Phase 3
Recruiting NCT06054867 - PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System N/A
Active, not recruiting NCT02435472 - Active Surveillance Exercise Clinical Trial N/A
Completed NCT02662673 - Evaluation of Focal Treatments of Localized Prostate Cancers With High Intensity Focused Ultrasound Using the Focal One® Device N/A
Recruiting NCT05155046 - 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy Phase 2
Completed NCT01902680 - Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant. Phase 2
Recruiting NCT00651417 - Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue Phase 2